Found: 30
Select item for more details and to access through your institution.
Clinically relevant therapeutic endpoints in type I Gaucher disease.
- Published in:
- Journal of Inherited Metabolic Disease, 2001, v. 24, p. 97, doi. 10.1023/A:1012492429191
- By:
- Publication type:
- Article
Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy.
- Published in:
- Journal of Inherited Metabolic Disease, 2001, v. 24, n. 2, p. 275, doi. 10.1023/A:1010335505357
- By:
- Publication type:
- Article
The natural course of Gaucher disease in The Netherlands: Implications for monitoring of disease manifestations.
- Published in:
- Journal of Inherited Metabolic Disease, 2000, v. 23, n. 1, p. 77, doi. 10.1023/A:1005655031239
- By:
- Publication type:
- Article
Oligosaccharide excretion in adult Gaucher disease.
- Published in:
- Journal of Inherited Metabolic Disease, 1998, v. 21, n. 1, p. 49, doi. 10.1023/A:1005311430722
- By:
- Publication type:
- Article
The quality of economic evaluations of ultraorphan drugs in Europe - a systematic review.
- Published in:
- Orphanet Journal of Rare Diseases, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13023-015-0305-y
- By:
- Publication type:
- Article
The quality of economic evaluations of ultra-orphan drugs in Europe - a systematic review.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Markers of bone turnover in Gaucher disease: modeling the evolution of bone disease.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 7, p. 2194, doi. 10.1210/jc.2011-0162
- By:
- Publication type:
- Article
Bone health in patients with inborn errors of metabolism.
- Published in:
- Reviews in Endocrine & Metabolic Disorders, 2018, v. 19, n. 1, p. 81, doi. 10.1007/s11154-018-9460-5
- By:
- Publication type:
- Article
Factors Contributing to the Efficacy-Effectiveness Gap in the Case of Orphan Drugs for Metabolic Diseases.
- Published in:
- Drugs, 2017, v. 77, n. 13, p. 1461, doi. 10.1007/s40265-017-0788-z
- By:
- Publication type:
- Article
Erratum to: Pain management strategies for neuropathic pain in Fabry disease - a systematic review.
- Published in:
- 2016
- By:
- Publication type:
- corrected article
Pain management strategies for neuropathic pain in Fabry disease--a systematic review.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Evaluation of miglustat as maintenance therapy after enzyme therapy on adults with stable type 1 Gaucher disease: a prospective, open-label non-inferiority study.
- Published in:
- Current Medical Literature: Lysosomal Storage Disease, 2013, v. 11, n. 2, p. 49
- By:
- Publication type:
- Article
Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Food or medicine? A European regulatory perspective on nutritional therapy products to treat inborn errors of metabolism.
- Published in:
- Journal of Inherited Metabolic Disease, 2023, v. 46, n. 6, p. 1017, doi. 10.1002/jimd.12677
- By:
- Publication type:
- Article
Evaluation of an imaging biomarker, Dixon quantitative chemical shift imaging, in Gaucher disease: lessons learned.
- Published in:
- Journal of Inherited Metabolic Disease, 2014, v. 37, n. 6, p. 1003, doi. 10.1007/s10545-014-9726-3
- By:
- Publication type:
- Article
Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.
- Published in:
- Journal of Inherited Metabolic Disease, 2014, v. 37, n. 6, p. 991, doi. 10.1007/s10545-014-9711-x
- By:
- Publication type:
- Article
Different dose-dependent correction of MIP-1β and chitotriosidase during initial enzyme replacement therapy.
- Published in:
- Journal of Inherited Metabolic Disease, 2009, v. 32, n. 2, p. 274, doi. 10.1007/s10545-009-1064-5
- By:
- Publication type:
- Article
Potential efficacy of enzyme replacement and substrate reduction therapy in three siblings with Gaucher disease type III.
- Published in:
- Journal of Inherited Metabolic Disease, 2008, v. 31, n. 6, p. 745, doi. 10.1007/s10545-008-0873-2
- By:
- Publication type:
- Article
Management of non-neuronopathic Gaucher disease with special reference to pregnancy, splenectomy, bisphosphonate therapy, use of biomarkers and bone disease monitoring.
- Published in:
- Journal of Inherited Metabolic Disease, 2008, v. 31, n. 3, p. 319, doi. 10.1007/s10545-008-0779-z
- By:
- Publication type:
- Article
‘Non-neuronopathic’ Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literature.
- Published in:
- Journal of Inherited Metabolic Disease, 2008, v. 31, n. 3, p. 337, doi. 10.1007/s10545-008-0832-y
- By:
- Publication type:
- Article
Hypermetabolism in Gaucher disease type I is not associated with altered thyroid hormone levels.
- Published in:
- 2007
- By:
- Publication type:
- Report
Home treatment with enzyme replacement therapy for mucopolysaccharidosis type I is feasible and safe.
- Published in:
- Journal of Inherited Metabolic Disease, 2007, v. 30, n. 6, p. 984, doi. 10.1007/s10545-007-0686-8
- By:
- Publication type:
- Article
Failure to detect Fabry patients in a cohort of prematurely atherosclerotic males.
- Published in:
- 2007
- By:
- Publication type:
- Report
Restricted upper extremity range of motion in mucopolysaccharidosis type I: no response to one year of enzyme replacement therapy.
- Published in:
- Journal of Inherited Metabolic Disease, 2007, v. 30, n. 1, p. 47, doi. 10.1007/s10545-006-0490-x
- By:
- Publication type:
- Article
The Dutch Fabry cohort: Diversity of clinical manifestations and Gb<sub>3</sub> levels.
- Published in:
- Journal of Inherited Metabolic Disease, 2007, v. 30, n. 1, p. 68, doi. 10.1007/s10545-006-0484-8
- By:
- Publication type:
- Article
Manifestations of Fabry disease in placental tissue.
- Published in:
- Journal of Inherited Metabolic Disease, 2006, v. 29, n. 1, p. 106, doi. 10.1007/s10545-006-0196-0
- By:
- Publication type:
- Article
Plasma chitotriosidase and CCL18: Early biochemical surrogate markers in type B Niemann-Pick disease.
- Published in:
- Journal of Inherited Metabolic Disease, 2005, v. 28, n. 1, p. 13, doi. 10.1007/s10545-005-4416-9
- By:
- Publication type:
- Article
Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease.
- Published in:
- Journal of Inherited Metabolic Disease, 2004, v. 27, n. 6, p. 757, doi. 10.1023/B:BOLI.0000045756.54006.17
- By:
- Publication type:
- Article
The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: A position statement.
- Published in:
- Journal of Inherited Metabolic Disease, 2003, v. 26, n. 6, p. 513, doi. 10.1023/A:1025902113005
- By:
- Publication type:
- Article
Angiokeratomas, Fabry disease and enzyme replacement therapy: still a challenge: reply from authors.
- Published in:
- 2005
- By:
- Publication type:
- Letter